These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7105057)

  • 1. Therapeutic effect of dopamine infusion on human malignant melanoma.
    Wick MM
    Cancer Treat Rep; 1982 Aug; 66(8):1657-9. PubMed ID: 7105057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapy of malignant melanoma.
    Wick MM
    J Invest Dermatol; 1983 Jun; 80 Suppl():61s-62s. PubMed ID: 6854056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant melanoma: local perfusions].
    Pettavel J
    Pathol Biol (Paris); 1990 Oct; 38(8):870-1. PubMed ID: 2274394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of lymphatic invasion: intra-arterial chemotherapy and curettage].
    Lasne E; Lodiot Y
    Soins Chir; 1984; (42-43):15-7. PubMed ID: 6569625
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic planning and prognosis in cutaneous malignant melanoma].
    Veronesi U; Cascinelli N; Preda F; Bastagli A
    Arch Ital Chir; 1969; 95(5):607-27. PubMed ID: 5407514
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells.
    Pisano M; Pagnan G; Loi M; Mura ME; Tilocca MG; Palmieri G; Fabbri D; Dettori MA; Delogu G; Ponzoni M; Rozzo C
    Mol Cancer; 2007 Jan; 6():8. PubMed ID: 17233906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives opened by intra-arterial chemotherapy in treatment of malignant cutaneous melanoma].
    Dargent M; Colon J; Mayer M; Moyne C; Estigarribia A
    Mem Acad Chir (Paris); 1967 Oct; 93(22):678-90. PubMed ID: 5623685
    [No Abstract]   [Full Text] [Related]  

  • 9. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
    Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
    Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extremity perfusion in malignant melanoma].
    Hohenberger W; Meyer T; Göhl J
    Chirurg; 1994 Mar; 65(3):175-85. PubMed ID: 8194401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
    Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F
    Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
    Glaspy J; Atkins MB; Richards JM; Agarwala SS; O'Day S; Knight RD; Jungnelius JU; Bedikian AY
    Cancer; 2009 Nov; 115(22):5228-36. PubMed ID: 19728370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma.
    Martín-Algarra S; Espinosa E; Rubió J; López López JJ; Manzano JL; Carrión LA; Plazaola A; Tanovic A; Paz-Ares L
    Eur J Cancer; 2009 Mar; 45(5):732-5. PubMed ID: 19186051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
    Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
    J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
    Schraffordt Koops H; Oldhoff J
    Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
    Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.